Pages that link to "Q42824740"

The following pages link to A plasmid-based self-amplifying Sindbis virus vector (Q42824740):

Displaying 48 items.

• Noncytopathic Sindbis virus RNA vectors for heterologous gene expression (Q27485983) (← links)
• A 'minimal' approach in design of flavivirus infectious DNA. (Q30308213) (← links)
• Alphavirus vectors: development and potential therapeutic applications (Q30771556) (← links)
• Alphaviruses as tools in neurobiology and gene therapy (Q33540007) (← links)
• Regulated expression of a Sindbis virus replicon by herpesvirus promoters (Q33653036) (← links)
• DNA and RNA-based vaccines: principles, progress and prospects (Q33783789) (← links)
• Nucleic acid vaccines: research tool or commercial reality (Q34023547) (← links)
• DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector (Q34069023) (← links)
• Alphavirus vectors for cancer therapy. (Q34130212) (← links)
• Coronavirus derived expression systems. (Q34297765) (← links)
• Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines (Q34573907) (← links)
• Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines. (Q34703631) (← links)
• Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways (Q34703643) (← links)
• Virus-based vectors for human vaccine applications (Q34731403) (← links)
• Alphavirus vectors and vaccination (Q34812016) (← links)
• Transfection of infectious RNA and DNA/RNA layered vectors of semliki forest virus by the cell-penetrating peptide based reagent PepFect6. (Q34828660) (← links)
• Virus-based gene delivery systems (Q34836871) (← links)
• Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors (Q35134462) (← links)
• DNA vaccines against human immunodeficiency virus type 1 in the past decade (Q35745831) (← links)
• Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA (Q35880542) (← links)
• Replication of flock house virus RNAs from primary transcripts made in cells by RNA polymerase II (Q35881935) (← links)
• Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques (Q36539048) (← links)
• Role of TLR3 in the immunogenicity of replicon plasmid-based vaccines. (Q37127370) (← links)
• Alphavirus-based expression vectors: strategies and applications (Q37250563) (← links)
• Gene therapy for malignant brain tumors (Q37610257) (← links)
• Vectorology and factor delivery in induced pluripotent stem cell reprogramming. (Q38195650) (← links)
• Replicon vectors derived from Sindbis virus and Semliki forest virus that establish persistent replication in host cells (Q39593506) (← links)
• Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine (Q39881368) (← links)
• Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives. (Q40471471) (← links)
• Sindbis virus vector system for functional analysis of apoptosis regulators (Q40865756) (← links)
• A temperature-regulated replicon-based DNA expression system (Q40889316) (← links)
• Gene therapy for neurologic disease: benchtop discoveries to bedside applications. 2. The bedside (Q40905286) (← links)
• Enhancing immune responses using suicidal DNA vaccines. (Q41034921) (← links)
• Alphaviruses as expression vectors (Q41082222) (← links)
• "Naked" DNA transfer technology for genetic vaccination against infectious disease (Q41435115) (← links)
• Alphavirus expression vectors and their use as recombinant vaccines: a minireview. (Q41499898) (← links)
• New applications of alphavirus-based expression vectors (Q42326934) (← links)
• Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination (Q43948614) (← links)
• Immunogenicity of a DNA-launched replicon-based canine parvovirus DNA vaccine expressing VP2 antigen in dogs (Q44609476) (← links)
• Rapid, high level protein production using DNA-based Semliki Forest virus vectors (Q45264524) (← links)
• Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein (Q45387980) (← links)
• A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge (Q45390287) (← links)
• Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice (Q45705186) (← links)
• Use of a Sindbis virus DNA-based expression vector for induction of protective immunity against pseudorabies virus in pigs (Q45722894) (← links)
• DNA vaccines with a kick (Q47980807) (← links)
• Semliki Forest VirusExpression System (Q56922178) (← links)
• Self-amplifying vectors for gene delivery (Q73850224) (← links)
• Recent advances in gene expression using alphavirus vectors (Q77576583) (← links)